CAS: 1186486-62-3 - Evacetrapib

Fórmula: C₃₁H₃₆F₆N₆O₂

InChI: InChI=1S/C31H36F6N6O2/c1-18-11-19(2)27-25(12-18)26(5-4-10-42(27)16-20-6-8-22(9-7-20)28(44)45)43(29-38-40-41(3)39-29)17-21-13-23(30(32,33)34)15-24(14-21)31(35,36)37/h11-15,20,22,26H,4-10,16-17H2,1-3H3,(H,44,45)/t20-,22-,26-/m0/s1

Clave InChI: InChIKey=IHIUGIVXARLYHP-YBXDKENTSA-N

SMILES: O=C(O)C1CCC(CN2C=3C(=CC(=CC3C(N(C=4N=NN(N4)C)CC=5C=C(C=C(C5)C(F)(F)F)C(F)(F)F)CCC2)C)C)CC1

Sinónimos:

• Cyclohexanecarboxylic acid, 4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-, trans-
• Ly-2484595
• Ly2484595
• trans-4-[[(5S)-5-[[[3,5-Bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]cyclohexanecarboxylic acid

Evacetrapib (LY2484595)

CAS: 1186486-62-3

• Fórmula: C₃₂H₃₇F₆N₅O₂
• Pureza: 98%
• Forma y color: Solid
• Peso molecular: 637.6589

Evacetrapib

CAS: 1186486-62-3

Evacetrapib (LY2484595) inhibits CETP strongly (IC50=5.5 nM), raises HDL cholesterol, no rise in aldosterone/blood pressure. …

• Fórmula: C₃₁H₃₆F₆N₆O₂
• Pureza: 98.53%
• Forma y color: Solid
• Peso molecular: 638.65